Mindfulness for Breast Cancer
| Status: | Recruiting |
|---|---|
| Conditions: | Anxiety, Anxiety, Breast Cancer, Cancer, Depression |
| Therapuetic Areas: | Oncology, Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 8/4/2018 |
| Start Date: | December 2015 |
| End Date: | March 2019 |
| Contact: | Amanda Shallcross |
| Email: | shalla01@nyumc.org |
Mindfulness Training to Improve Well-being in Post-Treatment Breast Cancer Patients
The primary purpose of this study is to evaluate the effects of Mindfulness Based Cognitive
Therapy (MBCT) vs. Treatment as Usual (TAU) for depression and anxiety symptoms in breast
cancer patients in recovery. Investigators will examine whether MBCT-related improvements in
sleep quality, illness-related distress, and rumination (escalating cycles of negative
thinking) predict MBCT-related decreases in depression and anxiety symptoms (Aim 2).
Exploratory analyses will examine whether demographics (e.g., age, sex, race/ethnicity),
individual differences (e.g., perceived stress, social support), clinical characteristics
(e.g., stage/severity of diagnosis), and treatment adherence (e.g., sessions attended, hours
of weekly practice) help determine for whom MBCT is most effective (Aim 3).
Therapy (MBCT) vs. Treatment as Usual (TAU) for depression and anxiety symptoms in breast
cancer patients in recovery. Investigators will examine whether MBCT-related improvements in
sleep quality, illness-related distress, and rumination (escalating cycles of negative
thinking) predict MBCT-related decreases in depression and anxiety symptoms (Aim 2).
Exploratory analyses will examine whether demographics (e.g., age, sex, race/ethnicity),
individual differences (e.g., perceived stress, social support), clinical characteristics
(e.g., stage/severity of diagnosis), and treatment adherence (e.g., sessions attended, hours
of weekly practice) help determine for whom MBCT is most effective (Aim 3).
Inclusion Criteria:
- Age 18 and over
- Able to speak and read English
- Diagnosis of breast cancer (any stage) for which active treatment (e.g., surgery,
chemotherapy, and/or radiotherapy) has been completed within 2 months to 2 years
Exclusion Criteria:
- Cognitive impairment or mental illness that would impair ability to provide consent or
participate in the program;
- Major psychiatric disorder (e.g., psychosis, personality disorder)
- Current suicidal ideation or suicide attempt within past 3 months
- Past participation in an MBCT group
We found this trial at
1
site
550 1st Ave
New York, New York 10016
New York, New York 10016
(212) 263-7300
Principal Investigator: Tanya Spruill
New York University School of Medicine NYU School of Medicine has a proud history that...
Click here to add this to my saved trials
